| [1] |
LUTGRING J D. Carbapenem-resistant Enterobacteriaceae: an emerging bacterial threat[J]. Semin Diagn Pathol, 2019, 36(3):182-186.
DOI
URL
|
| [2] |
袁余, 周丹, 廖全凤, 等. 某院临床样本中耐碳青霉烯肠杆菌目菌株的流行病学分析[J]. 四川大学学报(医学版), 2023, 54(3):602-607.
|
| [3] |
LING Z, YIN W, SHEN Z, et al. Epidemiology of mobile colistin resistance genes mcr-1 to mcr-9[J]. J Antimicrob Chemother, 2020, 75(11):3087-3095.
DOI
URL
|
| [4] |
SUAY-GARCÍA B, PÉREZ-GRACIA M T. Present and future of carbapenem-resistant Enterobacteriaceae(CRE)infections[J]. Antibiotics(Basel), 2019, 8(3):122.
|
| [5] |
PAUL M, CARRARA E, RETAMAR P, et al. European society of clinical microbiology and infectious diseases(ESCMID)guidelines for the treatment of infections caused by multidrug-resistant gram-negative bacilli(endorsed by European society of intensive care medicine)[J]. Clin Microbiol Infect, 2022, 28(4):521-547.
DOI
URL
|
| [6] |
DURANTE-MANGONI E, ANDINI R, ZAMPINO R. Management of carbapenem-resistant Enterobacteriaceae infections[J]. Clin Microbiol Infect, 2019, 25(8):943-950.
DOI
URL
|
| [7] |
王家良, 康德英.临床流行病学——临床科研设计、 测量与评价[M]. 上海: 上海科学技术出版社, 2021.
|
| [8] |
HUANG J, ZHAO J, YI M, et al. Emergence of tigecycline and carbapenem-resistant Citrobacter freundii co-carrying tmexCD1-toprJ1,blaKPC-2,and blaNDM-1 from a sepsis patient[J]. Infect Drug Resist, 2023,16:5855-5868.
|
| [9] |
张奥, 千晨静, 韦若文, 等. 血液病患者造血干细胞移植后血流感染及耐碳青霉烯类革兰阴性杆菌定植的重点菌群监测和临床分析[J]. 中华血液学杂志, 2024, 45(2):134-140.
|
| [10] |
方会慧, 许元宝, 孙旭群, 等. 替加环素治疗血液系统恶性肿瘤并发感染的疗效及其影响因素[J]. 中国感染控制杂志, 2021, 20(6):505-511.
|
| [11] |
LI Q, ZHANG X, DING Y, et al. Association of length of hospital stay,total body surface area burned,and carbapenem-resistant Klebsiella pneumoniae infection in burn patients:a retrospective study[J]. Burns, 2024, 50(8):2007-2012.
DOI
URL
|
| [12] |
王雨豪, 邵蔚, 圣玉良, 等. 碳青霉烯类耐药肠杆菌科细菌血流感染危险因素及其列线图模型的建立[J]. 中华医院感染学杂志, 2023, 33(15):2251-2255.
|
| [13] |
WU W, WANG J, ZHANG P, et al. Emergence of carbapenem-resistant Enterobacter hormaechei ST93 plasmids co-harbouring blaNDM-1,blaKPC-2,and mcr-9 in bloodstream infection[J]. J Glob Antimicrob Resist, 2023,34:67-73.
|
| [14] |
LIN M, YANG Y, YANG Y, et al. Co-occurrence of mcr-9 and blaNDM-1 in Enterobacter cloacae isolated from a patient with bloodstream infection[J]. Infect Drug Resist, 2020,13:1397-1402.
|
| [15] |
WANG M, JIN L, WANG R, et al. KpnK48 clone driving hypervirulent carbapenem-resistant Escherichia coli epidemics:insights into its evolutionary trajectory similar to Klebsiella pneumoniae[J]. Drug Resist Updat, 2025,81:101243.
|
| [16] |
朱昱蓉, 刘荣华. 肺炎克雷伯菌、类肺炎克雷伯菌和变栖克雷伯菌的研究进展[J]. 中国感染控制杂志, 2023, 22(8):983-989.
|
| [17] |
薛野, 邹超世, 李泰阶, 等. 老年患者耐碳青霉烯类鲍曼不动杆菌血流感染的危险因素和病死率:一项为期十年的回顾性研究[J]. 中国感染控制杂志, 2024, 23(2):155-161.
|
| [18] |
任亚璐, 吴逸宁, 邱善敏, 等. 血液肿瘤患者肛拭子耐碳青霉烯类肠杆菌目主动筛查情况及继发血流感染的影响因素[J]. 中国现代医学杂志, 2023, 33(21):16-21.
|
| [19] |
胥萍瑶, 倪苏娇, 张开炯, 等. 恶性肿瘤患者ESKAPE病原菌血流感染临床特征和危险因素分析[J]. 四川大学学报(医学版), 2020, 51(4):567-572.
|
| [20] |
孔令慧, 于杰, 张会君, 等. 基于Logistic回归和决策树的老年脑卒中病人肌少症风险预测模型的构建[J]. 护理研究, 2024, 38(10):1703-1710.
|
| [21] |
WEN Z, NIE X, CHEN L, et al. A decision tree model to help treatment decision-making for unruptured intracranial aneurysms:a multi-center,long-term follow-up study in a large Chinese cohort[J]. Transl Stroke Res, 2025, 16(4):1062-1074.
DOI
|
| [22] |
贾辰, 王璐, 李海峰. ICU住院患者耐碳青霉烯类肺炎克雷伯菌感染危险因素及其BP神经网络模型的预测价值[J]. 中华医院感染学杂志, 2024, 34(12):1778-1783.
|